Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians
Kimberly Anne Gudzune of @HopkinsMedicine, recorded @SocietyGIM #SGIM23 in Denver, Colorado Show Segments Intro Barriers to treating medicine in primary care Patient counseling and obesity pathophysiology Motivational Interviewing Telemedicine for obesity Tools and tips for a weight loss program Medications for Obesity GLP1 agonist prescribing tips Outro Obesity Medicine Pearls Obesity is a chronic disease
Eligible participants were men or women aged 5585 years with mild cognitive impairment or mild dementia due to AD with confirmed amyloid abnormalities (assessed by positron emission tomography or cerebrospinal fluid [CSF] analysis)
This approach helps you build strength and endurance safely
Common side effects include nausea, heartburn, abdominal pain, vomiting or diarrhea
GLP-1 expansion implications In addition to weight loss, GLP-1s are also being evaluated to treat common conditions such as cardiovascular disease, chronic kidney disease, Alzheimers disease, and even sleep apnea
